BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8087860)

  • 1. Estrogen induces suppression of natural killer cell cytotoxicity and augmentation of polyclonal B cell activation.
    Nilsson N; Carlsten H
    Cell Immunol; 1994 Oct; 158(1):131-9. PubMed ID: 8087860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of B-cell differentiation by natural killer (asialo GM1+) cells in mice.
    Suzuki S; Suzuki R; Onta T; Kumagai K
    Nat Immun Cell Growth Regul; 1986; 5(2):75-89. PubMed ID: 3487716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asialo-GM1+ natural killer cells directly suppress antibody-producing B cells.
    Robles CP; Pollack SB
    Nat Immun Cell Growth Regul; 1989; 8(4):209-22. PubMed ID: 2797013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
    Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
    Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related variation in the proportion and activity of murine liver natural killer cells and their cytotoxicity against regenerating hepatocytes.
    Itoh H; Abo T; Sugawara S; Kanno A; Kumagai K
    J Immunol; 1988 Jul; 141(1):315-23. PubMed ID: 3379309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vivo role of murine natural killer cells in the development of B cell lineage in bone marrow.
    Tamauchi H; Shimamura K; Okumura K; Habu S; Tamaoki N
    Tokai J Exp Clin Med; 1985 Dec; 10(6):621-9. PubMed ID: 3915838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell suppression of IgM production.
    Che S; Huston DP
    Nat Immun; 1994; 13(5):258-69. PubMed ID: 7833625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
    Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations.
    Ghayur T; Seemayer TA; Lapp WS
    Transplantation; 1987 Aug; 44(2):254-60. PubMed ID: 3498241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of suppressed natural killer cell activity with altered host resistance models in B6C3F1 mice.
    Wilson SD; McCay JA; Butterworth LF; Munson AE; White KL
    Toxicol Appl Pharmacol; 2001 Dec; 177(3):208-18. PubMed ID: 11749120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG.
    Shimada S; Yano O; Tokunaga T
    Jpn J Cancer Res; 1986 Aug; 77(8):808-16. PubMed ID: 2428798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of natural killer cell lines from murine long-term bone marrow cultures.
    Yung YP; Okumura K; Moore MA
    J Immunol; 1985 Mar; 134(3):1462-8. PubMed ID: 3968424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-asialo GM1 antibody suppression of cyclophosphamide-induced diabetes in NOD mice.
    Maruyama T; Watanabe K; Takei I; Kasuga A; Shimada A; Yanagawa T; Kasatani T; Suzuki Y; Kataoka K; Saruta
    Diabetes Res; 1991 May; 17(1):37-41. PubMed ID: 1823558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of suppressor cells in the decline of natural killer cell activity in estrogen-treated mice.
    Milisauskas VK; Cudkowicz G; Nakamura I
    Cancer Res; 1983 Nov; 43(11):5240-3. PubMed ID: 6225513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells.
    Grönberg A; Hansson M; Kiessling R; Andersson B; Kärre K; Roder J
    J Natl Cancer Inst; 1980 May; 64(5):1113-9. PubMed ID: 6966004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid).
    Dorshkind K; Pollack SB; Bosma MJ; Phillips RA
    J Immunol; 1985 Jun; 134(6):3798-801. PubMed ID: 3989296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of natural killer cytolytic activity in mice undergoing pulmonary granulomatous inflammation.
    Remick DG; Kunkel SL; Higashi GI; Hiserodt JC
    J Immunol; 1988 Apr; 140(7):2225-30. PubMed ID: 3127462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of alternative or concomitant use of perforin- and Fas-dependent pathways in a T cell-mediated negative regulation of Ig production.
    Majlessi L; Bordenave G
    J Immunol; 1999 Apr; 162(8):4391-8. PubMed ID: 10201974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
    Majlessi L; Bordenave G
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.